Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acute Respiratory Distress Syndrome in Taiwan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03260348
Recruitment Status : Not yet recruiting
First Posted : August 24, 2017
Last Update Posted : August 24, 2017
Sponsor:
Information provided by (Responsible Party):
Chang Gung Memorial Hospital

Tracking Information
First Submitted Date August 22, 2017
First Posted Date August 24, 2017
Last Update Posted Date August 24, 2017
Estimated Study Start Date September 1, 2017
Estimated Primary Completion Date January 31, 2018   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: August 22, 2017)
  • Epidemiology [ Time Frame: two months ]
    The incidence of ARDS in intensive care unit
  • Mortality [ Time Frame: 90 days ]
    The mortality rate of patients in hospital
  • Long-term outcome [ Time Frame: 5 years ]
    Performance status of live patients discharged.
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Acute Respiratory Distress Syndrome in Taiwan
Official Title Epidemiology and Long-term Outcomes of Patients With Acute Respiratory Distress Syndrome in Taiwan
Brief Summary The study enrolls ARDS patients in medical ICUs in 11 Hospitals in Taiwan. The epidemiology and long-term outcomes of the patients will be recorded.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population All patients in medical intensive care unit during study period.
Condition Acute Respiratory Distress Syndrome
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Not yet recruiting
Estimated Enrollment
 (submitted: August 22, 2017)
2000
Original Estimated Enrollment Same as current
Estimated Study Completion Date January 31, 2023
Estimated Primary Completion Date January 31, 2018   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Age >18 years
  • Patients in medical intensive care unit in Sep., 2017 and Jan., 2018.

Exclusion Criteria:

  • Age less than 18 years.
  • Pregnancy.
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts
Contact: Kuo-Chin Kao kck0502@cgmh.org.tw
Contact: Tsang-Tang Hsieh 886-3-3196200 ext 3711
Listed Location Countries Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number NCT03260348
Other Study ID Numbers 201701188B0
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: No
Responsible Party Chang Gung Memorial Hospital
Study Sponsor Chang Gung Memorial Hospital
Collaborators Not Provided
Investigators
Principal Investigator: Kuo-Chin Kao Chang Gung Memorial Hospital
PRS Account Chang Gung Memorial Hospital
Verification Date August 2017